PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 91 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $13,185,000 | -50.0% | 347,349 | -62.7% | 5.61% | -25.1% |
| Q4 2014 | $26,357,000 | +12.0% | 930,682 | 0.0% | 7.49% | -46.8% |
| Q3 2014 | $23,528,000 | -35.0% | 930,682 | -25.0% | 14.07% | -16.4% |
| Q2 2014 | $36,210,000 | +12.7% | 1,240,912 | 0.0% | 16.83% | -5.1% |
| Q1 2014 | $32,140,000 | +0.6% | 1,240,912 | 0.0% | 17.73% | -26.4% |
| Q4 2013 | $31,953,000 | -3.7% | 1,240,912 | -0.0% | 24.08% | +27.3% |
| Q3 2013 | $33,195,000 | +8.8% | 1,240,917 | 0.0% | 18.92% | -19.4% |
| Q2 2013 | $30,502,000 | – | 1,240,917 | – | 23.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |